Breaking News Instant updates and real-time market news.

PNR

Pentair

$45.41

-0.53 (-1.15%)

, AA

Alcoa

$20.84

-0.155 (-0.74%)

10:08
12/17/19
12/17
10:08
12/17/19
10:08

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pentair (PNR) downgraded to Hold from Buy at Stifel with analyst Nathan Jones saying Pentair's 2020 prospects look improved over 2019 where discrete headwinds, particularly in the Aquatics business, create easy comparisons in the first half of 2020. 2. Alcoa (AA) downgraded to Market Perform from Outperform at BMO Capital with analyst David Gagliano saying BMO's reduced aluminum price forecasts for the entirety of the aluminum supply chain leave "little incremental upside potential" moving forward in the underlying price forecasts. 3. SciPlay (SCPL) was double downgraded to Sell from Buy at Goldman Sachs while Groupon (GRPN) was downgraded to Sell from Neutral. 4. Lennar (LEN) and Fortune Brands (FBHS) were downgraded to Sector Perform from Outperform at RBC Capital while D.R. Horton (DHI) was downgraded to Underperform from Sector Perform. 5. Alexion (ALXN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Matthew Harrison saying while he thinks the company can effectively transition Soliris to Ultomiris and maintain its large and emerging neurology franchise, he does not see the "major overhang of concentration risk" as one the company will be able to address in the near-term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PNR

Pentair

$45.41

-0.53 (-1.15%)

AA

Alcoa

$20.84

-0.155 (-0.74%)

GRPN

Groupon

$2.46

-0.17 (-6.46%)

SCPL

SciPlay

$11.70

-1.1 (-8.59%)

LEN

Lennar

$57.80

-0.27 (-0.46%)

DHI

D.R. Horton

$54.45

-0.27 (-0.49%)

FBHS

Fortune Brands

$65.61

0.14 (0.21%)

ALXN

Alexion

$109.55

-1.82 (-1.63%)

  • 17

    Dec

PNR Pentair
$45.41

-0.53 (-1.15%)

12/17/19
STFL
12/17/19
DOWNGRADE
Target $46
STFL
Hold
Pentair downgraded to Hold from Buy at Stifel
Stifel analyst Nathan Jones downgraded Pentair to Hold from Buy with an unchanged price target of $46. Pentair's 2020 prospects look improved over 2019 where discrete headwinds, particularly in the Aquatics business, create easy comparisons in the first half of 2020, Jones tells investors in a research note. However, the analyst believes the share price currently reflects the company's improved short term prospects. He views the stock as reasonably valued at current levels.
12/17/19
SBSH
12/17/19
INITIATION
Target $50
SBSH
Neutral
Pentair initiated with a Neutral at Citi
Citi analyst Andrew Kaplowitz initiated coverage of Pentair with a Neutral rating and $50 price target. The analyst sees risks to Pentair with the company in the early innings of accomplishing its residential and commercial filtration strategy and potentially limited growth in some of its end markets. He sees a balanced risk/reward at current share levels.
12/09/19
KEYB
12/09/19
UPGRADE
Target $52
KEYB
Overweight
Pentair upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Jeffrey Hammond upgraded Pentair (PNR) to Overweight from Sector Weight with a $52 price target. In a research note to investors, Hammond says Pentair is replacing A.O. Smith (AOS) as his preferred Water play, saying that while he sees an opportunity for both companies to improve materially off a low earnings base next year, he has higher confidence in Pentair fully stabilizing by year-end, clearing the path for an inflection at the onset of 2020.
12/09/19
KEYB
12/09/19
DOWNGRADE
KEYB
Sector Weight
A.O. Smith downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Jeffrey Hammond downgraded A.O. Smith (AOS) to Sector Weight from Overweight. In a reteach note to investors, Hammond says he is replacing A.O. Smith with Pentair (PNR) as his preferred Water play, saying that while he sees an opportunity for both companies to improve materially off a low earnings base next year, he has higher confidence in Pentair fully stabilizing by year-end, clearing the path for an inflection at the onset of 2020, whereas he sees the potential for challenges in China to linger into 1H20 alongside a still-unsettled political landscape and Haier to disrupt what was a long- established three-player oligopoly in the North American water heater market, all dampening his optimism for A.O. Smith both near and longer term.
AA Alcoa
$20.84

-0.155 (-0.74%)

11/13/19
11/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Skyworks (SWKS) downgraded to Hold from Buy at Canaccord with analyst T. Michael Walkley saying he believes the company is well positioned to grow faster than the broader semi market for the next several years due to smartphone mix among Chinese OEMs requiring integrated Rf solutions, growing IoT opportunities, and the ramping 5G market opportunities. 2. D.R. Horton (DHI) downgraded to Neutral from Buy at Buckingham. 3. Diplomat Pharmacy (DPLO) downgraded to Equal Weight from Overweight at Barclays with analyst Steven Valiquette saying Diplomat's strategic review is ongoing, which could lead to a sale of the entire company, or simultaneous asset sales that could unlock value. 4. Alcoa (AA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Timna Tanners citing limited catalysts and a cautious aluminum view, adding that while the stock price has risen about 16% since reporting Q3, aluminum price was up only about 6% in that time frame. 5. J.M. Smucker (SJM) downgraded to Underperform from Neutral at Credit Suisse with analyst Robert Moskow saying with consensus already below management's FY20 guidance of $8.35-$8.55, it is fair to say that J.M. Smucker is already an out-of-favor stock, but he believes that consensus and the market underestimate the extent to which earnings will need to be revised lower as structural challenges continue to mount. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/19
BOFA
11/13/19
DOWNGRADE
Target $21
BOFA
Underperform
Alcoa downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Timna Tanners downgraded Alcoa to Underperform from Neutral with a $21 price target. The analyst cites limited catalysts and a cautious aluminum view, adding that while the stock price has risen about 16% since reporting Q3, aluminum price was up only about 6% in that time frame. Tanners adds that investors may be "overly enthusiastic" regarding the cost savings implied in the company's review.
11/13/19
BOFA
11/13/19
DOWNGRADE
BOFA
Underperform
Alcoa downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded Alcoa to Underperform from Neutral.
12/17/19
BMOC
12/17/19
DOWNGRADE
Target $23
BMOC
Market Perform
Alcoa downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst David Gagliano downgraded Alcoa to Market Perform from Outperform with a price target of $23, down from $25. The analyst says BMO's reduced aluminum price forecasts for the entirety of the aluminum supply chain leave "little incremental upside potential" moving forward in the underlying price forecasts. With Alcoa shares highly sensitive to underlying price forecasts, there are limited price-related catalysts to push the stock higher in 2020, Gagliano tells investors in a research note.
GRPN Groupon
$2.46

-0.17 (-6.46%)

12/17/19
GSCO
12/17/19
DOWNGRADE
Target $2.4
GSCO
Sell
Groupon downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng downgraded Groupon to Sell from Neutral with a $2.40 price target. The analyst cites execution risks in North America following 7 consecutive quarters of customer declines going back to Q1 of 2018, with traffic headwinds in the market weighing on the company's revenue, billings, and gross profit declines anticipated for 2020-21. Ng remains positive on Groupon's international opportunity longer term, but also points to the recent negative inflection in the overseas markets.
11/06/19
11/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Groupon (GRPN) downgraded to Underweight from Neutral at JPMorgan with analyst Doug Anmuth saying while he is encouraged by the company's efforts toward improving customer conversion, he thinks those efforts will take time to offset traffic and international macro headwinds. 2. Altice USA (ATUS) downgraded to Sector Weight from Overweight at KeyBanc and to Equal Weight from Overweight at Barclays. 3. Prudential (PRU) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Ryan Krueger saying to reflect softer business growth and lower individual annuity margins, he further reduced his estimates for Prudential. 4. KeyCorp (KEY) downgraded to Neutral from Outperform at Baird with analyst David George saying shares have reached his price target and although he is comfortable with the company outlook, he would wait for a better entry point for the shares. George maintained his $19 price target on KeyCorp shares. 5. WW (WW) downgraded to Neutral from Buy at DA Davidson with analyst Linda Weiser saying subscribers exceeded her estimate in the quarter, but that did not translate to gross margin upside, which is concerning given the dampening effect on sales of the studio to digital shift. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/19
JPMS
11/06/19
DOWNGRADE
JPMS
Underweight
JPMorgan cuts Groupon to Underweight, sees conversion improvement taking time
As previously reported, JPMorgan analyst Doug Anmuth downgraded Groupon to Underweight from Neutral after the company reported weaker than expected Q3 earnings and revenue that was 6% below his estimate. While he is encouraged by the company's efforts toward improving customer conversion, he thinks those efforts will take time to offset traffic and international macro headwinds. Ultimately, Anmuth sees it being very difficult to offset the "significant external issues challenging the core business" and believes pressures will continue to weigh despite the stock's low valuation. He has no price target on Groupon shares.
12/17/19
GSCO
12/17/19
DOWNGRADE
Target $2.4
GSCO
Sell
Groupon downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng downgraded Groupon to Sell from Neutral with a $2.40 price target. The analyst cites traffic challenges and ongoing customer churn for the downgrade.
SCPL SciPlay
$11.70

-1.1 (-8.59%)

09/19/19
BOFA
09/19/19
DOWNGRADE
BOFA
Underperform
SciPlay downgraded to Underperform from Buy at BofA/Merrill
12/17/19
GSCO
12/17/19
DOWNGRADE
Target $10
GSCO
Sell
SciPlay double-downgraded to Sell from Buy at Goldman Sachs
Goldman Sachs analyst Michael Ng double-downgraded SciPlay to Sell from Buy with a price target of $10, down from $12. The analyst is citing "stagnant bookings" of the 88 Fortunes, Quick Hit, Gold Fish, and Hot Shot Casino slot portfolio along with "slowing momentum" for Bingo and Monopoly lines, suggesting that the company's transition toward emerging casual games "not based on real world slot machines" may be more difficult than originally anticipated.
12/17/19
GSCO
12/17/19
DOWNGRADE
Target $10
GSCO
Sell
SciPlay downgraded to Sell from Buy at Goldman Sachs
Goldman Sachs analyst Michael Ng double downgraded SciPlay to Sell from Buy with a $10 price target on lower confidence in the company's slots portfolio..
09/19/19
BOFA
09/19/19
DOWNGRADE
Target $12
BOFA
Underperform
SciPlay downgraded two notches to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Ryan Gee issued a double-downgrade of SciPlay to Underperform from Buy and lowered his price target on the shares to $12 from $17. The analyst notes that the company's growth has been softer-than-expected since its IPO and its upcoming Q3 results are tracking to be in-line with expectations, even though Activision Blizzard (ATVI) and Take-Two (TTWO) are headed toward upside. Gee also attributes the rating change to higher exposure to potential regulation of mobile casino games, threat of competition from legalized mobile slot games, and limited upcoming catalysts in terms of new games or new markets to generate upside.
LEN Lennar
$57.80

-0.27 (-0.46%)

12/17/19
RBCM
12/17/19
DOWNGRADE
Target $62
RBCM
Sector Perform
Lennar downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Michael Dahl downgraded Lennar to Sector Perform from Outperform with a $62 price target.
12/06/19
GSCO
12/06/19
INITIATION
Target $71
GSCO
Buy
Lennar initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Susan Maklari initiated coverage of Lennar with a Buy rating and $71 price target. The analyst initiated coverage of six homebuilding stocks with a positive sector view as her analysis of the housing market points to an acceleration in activity next year given an accommodative rate environment with broader economic expansion.
12/17/19
RBCM
12/17/19
DOWNGRADE
Target $62
RBCM
Sector Perform
Lennar downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Michael Dahl downgraded Lennar to Sector Perform from Outperform with a price target of $62, down from $63. The analyst still sees the company as well positioned to drive above-market growth and margins thanks to the integration and synergy realization of its CalAtlantic acquisition, but sees its valuation offering only modest upside potential.
10/03/19
RBCM
10/03/19
NO CHANGE
Target $63
RBCM
Lennar price target raised to $63 from $59 at RBC Capital
RBC Capital analyst Mike Dahl raised his price target on Lennar (LEN) to $63 and kept his Outperform rating after its Q3 earnings beat and strong Q4 guide as well as "decidedly more positive" tone by its management on the call. The analyst notes that in spite of the macro uncertainty, the housing demand is "clearly" stronger amid improving affordability and healthy employment backdrop. Dahl anticipates a positive inflection in forward earnings estimates for Lennar, allowing the stock to narrow its valuation gap relative to D.R. Horton (DHI) and PulteGroup (PHM).
DHI D.R. Horton
$54.45

-0.27 (-0.49%)

12/06/19
GSCO
12/06/19
INITIATION
Target $51
GSCO
Sell
D.R. Horton initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Susan Maklari initiated coverage of D.R. Horton with a Sell rating and $51 price target. The analyst initiated coverage of six homebuilding stocks with a positive sector view as her analysis of the housing market points to an acceleration in activity next year given an accommodative rate environment with broader economic expansion. However, she believes this is already captured in the stock of D.R. Horton. The analyst looks for multiple contraction as Street expectations start to align more closely to the company's fiscal 2020 guidance.
12/12/19
ZELM
12/12/19
NO CHANGE
ZELM
Toll Brothers added to Top Idea Basket at Zelman
Analysts at Zelman said the 5% selloff in shares of Toll Brothers (TOL) following earnings is unjustified and they added the stock to their Top Idea Basket, swapping it in and D.R. Horton (DHI) out. However, Zelman maintains a Buy rating on D.R. Horton shares.
12/17/19
RBCM
12/17/19
DOWNGRADE
Target $51
RBCM
Underperform
D.R. Horton downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital analyst Michael Dahl downgraded D.R. Horton to Underperform from Sector Perform with a price target of $51, down from $52. The analyst notes that while the company's growth will remain healthy in 2020, it will match its peers amid more difficult comparisons and greater entry-level competition in the entry level homebuilding space. Dahl also believes that D.R. Horton's gross margin guidance offers little upside.
12/17/19
RBCM
12/17/19
DOWNGRADE
Target $51
RBCM
Underperform
D.R. Horton downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital analyst Michael Dahl downgraded D.R. Horton to Underperform from Sector Perform with a $51 price target.
FBHS Fortune Brands
$65.61

0.14 (0.21%)

12/17/19
RBCM
12/17/19
DOWNGRADE
Target $67
RBCM
Sector Perform
Fortune Brands downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Michael Dahl downgraded Fortune Brands Home & Security to Sector Perform from Outperform with a $67 price target.
12/17/19
RBCM
12/17/19
DOWNGRADE
Target $67
RBCM
Sector Perform
Fortune Brands downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Michael Dahl downgraded Fortune Brands to Sector Perform from Outperform with a $67 price target. The analyst is citing the company's valuation, with the stock turning into a "consensus buy-side long". Dahl believes that expectations may have become "too optimistic" in reflecting the near-term trajectory of the cabinets business following the antidumping tariffs.
12/13/19
JEFF
12/13/19
NO CHANGE
JEFF
Buy
Masco, Fortune Brands beneficiaries of phase one trade deal, says Jefferies
Jefferies analyst Philip Ng said among building products companies he sees Masco (MAS) and Fortune Brands (FBHS) as the biggest beneficiaries. A roll back of 50% of the existing tariffs could boost Masco's EPS by 6% and add 3% to earnings for Fortune, estimates Ng. He also believes demand should lift as well, estimating that every 1% rise in volumes translates to a 1% increase in EPS for these two companies. Ng keeps Buy ratings on both stocks.
12/06/19
GSCO
12/06/19
INITIATION
Target $74
GSCO
Buy
Fortune Brands initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Susan Maklari initiated coverage of Fortune Brands with a Buy rating and $74 price target. Although 2019 headwinds proved to be stronger than expected, Fortune's efforts across its operations should drive results ahead of expectations in 2020, Maklari tells investors in a research note. The analyst highlights the company's repositioning of cabinets under a new leadership team, its above-average growth in Fiberon, and the ongoing strength in the global plumbing group.
ALXN Alexion
$109.55

-1.82 (-1.63%)

12/05/19
PIPR
12/05/19
NO CHANGE
PIPR
Overweight
Piper Jaffray a buyer of Alexion shares on weakness after pozelimab data
Piper Jaffray analyst Christopher Raymond said he remains a "steadfast" bull on Alexion (ALXN) and would be a buyer of the shares amid the weakness today following Regeneron's (REGN) announcement of topline data from the pozelimab Phase 2 clinical program in paroxysmal nocturnal hemoglobinuria, or PNH. While six patients is "a fairly meaningful sample size" in this indication, Raymond said that "many questions remain," including patient baseline characteristics and patient specific data. It is difficult to compare the data to Soliris/Ultomiris without having more insight, added Raymond, who said he thinks "investors would do well to take a few steps back before reacting" to today's pozelimab release. The analyst, who prefers to wait for "a more fulsome update" before jumping to any conclusions, views today's stock reaction as overblown and he keeps an Overweight rating on Alexion shares, which are down 7% in afternoon trading.
12/17/19
MSCO
12/17/19
DOWNGRADE
Target $128
MSCO
Equal Weight
Morgan Stanley cuts Alexion to Equal Weight on continued concentration risk
Morgan Stanley analyst Matthew Harrison downgraded Alexion to Equal Weight from Overweight with a price target of $128, down from $170. While he thinks the company can effectively transition Soliris to Ultomiris and maintain its large and emerging neurology franchise, Harrison does not see the "major overhang of concentration risk" as one the company will be able to address in the near-term, he tells investors. He thinks the company will have to disprove the negative notion that it will face significant erosion when biosimilars launch or engage in "much more sizeable" M&A in order to close "the gap between intrinsic and market value," Harrison added.
12/17/19
MSCO
12/17/19
DOWNGRADE
Target $128
MSCO
Equal Weight
Alexion downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison downgraded Alexion Pharmaceuticals to Equal Weight from Overweight with a $128 price target.
12/09/19
PIPR
12/09/19
NO CHANGE
PIPR
Piper Jaffray recommends Alexion following topline Phase 2 data
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating and $180 price target on Alexion (ALXN) in a note titled "Positive P2 Danicopan PNH Update; P3 Initiation Expected in Early 2020." The analyst viewed the topline Phase 2 data on Achillion's (ACHN) Danicopan in combination with Soliris as "yet another supportive data point" for his hypothesis that combining the two drug therapies "makes sense." Raymond noted that Alexion's acquisition of Achillion is on track to close in the first half of 2020, and he was positive on how Alexion is broadening and diversifying its portfolio.

TODAY'S FREE FLY STORIES

SWK

Stanley Black & Decker

$171.74

1.29 (0.76%)

14:49
01/17/20
01/17
14:49
01/17/20
14:49
Periodicals
Stanley Black & Decker in talks to buy Consolidated Aerospace, Reuters says »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

AAPL

Apple

$316.97

1.64 (0.52%)

14:49
01/17/20
01/17
14:49
01/17/20
14:49
Periodicals
Apple may have to abandon lightning connector cable in Europe, BBC News says »

Members of the European…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

SWK

Stanley Black & Decker

$171.72

1.27 (0.75%)

14:45
01/17/20
01/17
14:45
01/17/20
14:45
Periodicals
Stanley Black & Decker in talks to buy Consolidated Aerospace, Reuters says »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

LSCC

Lattice Semiconductor

$23.15

1.87 (8.79%)

, AAPL

Apple

$316.57

1.24 (0.39%)

14:39
01/17/20
01/17
14:39
01/17/20
14:39
Hot Stocks
Lattice Semiconductor rises as link to Apple acquisition highlighted »

Following a report from…

LSCC

Lattice Semiconductor

$23.15

1.87 (8.79%)

AAPL

Apple

$316.57

1.24 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

DB

Deutsche Bank

$8.43

-0.115 (-1.35%)

14:32
01/17/20
01/17
14:32
01/17/20
14:32
Periodicals
Deutsche Bank slashes investment bank bonuses by roughly 30%, Bloomberg says »

Deutsche Bank is lowering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

14:30
01/17/20
01/17
14:30
01/17/20
14:30
Options
MIAX SPIKES options volume over 100K contracts is new record »

MIAX SPIKES options…

INSG

Inseego

$9.23

0.76 (8.97%)

14:25
01/17/20
01/17
14:25
01/17/20
14:25
Options
Inseego call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSTG

NanoString

$30.44

-0.41 (-1.33%)

14:23
01/17/20
01/17
14:23
01/17/20
14:23
Hot Stocks
Pura Vida reports 5.37% passive stake in NanoString »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/17/20
01/17
14:17
01/17/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/17/20
01/17
14:16
01/17/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$70.39

-4.05 (-5.44%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Hot Stocks
Lawmakers urge FTC to investigate Envestnet over sale of financial data »

Several U.S. lawmakers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SNCA

Seneca Biopharma

$3.80

2.55 (204.00%)

14:06
01/17/20
01/17
14:06
01/17/20
14:06
Syndicate
Seneca Biopharma announces exercise of warrants for $7.55M gross proceeds »

Seneca Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHT

DHT Holdings

$7.41

0.19 (2.63%)

14:05
01/17/20
01/17
14:05
01/17/20
14:05
Options
DHT Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
01/17/20
01/17
14:05
01/17/20
14:05
General news
Action Economics Survey results: »

Action Economics Survey…

BGNE

BeiGene

$169.60

1.72 (1.02%)

14:03
01/17/20
01/17
14:03
01/17/20
14:03
Upgrade
BeiGene rating change  »

BeiGene upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SNE

Sony

$72.46

-0.09 (-0.12%)

, CMCSA

Comcast

$47.43

0.57 (1.22%)

13:57
01/17/20
01/17
13:57
01/17/20
13:57
On The Fly
Box Office Battle: 'Bad Boys for Life' opens strong »

Welcome to "Box Office…

SNE

Sony

$72.46

-0.09 (-0.12%)

CMCSA

Comcast

$47.43

0.57 (1.22%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$38.33

0.3 (0.79%)

DIS

Disney

$144.67

-0.43 (-0.30%)

LGF.A

Lionsgate

$10.94

-0.34 (-3.01%)

LGF.B

Lionsgate

$10.30

-0.325 (-3.06%)

VIAC

ViacomCBS

$39.64

-0.41 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 04

    Feb

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

BA

Boeing

$325.18

-6.82 (-2.05%)

13:46
01/17/20
01/17
13:46
01/17/20
13:46
Periodicals
Boeing tells CNBC 'making necessary updates' to MAX after report of new issue »

After ABC's David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$326.24

-5.76 (-1.73%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing down 2% to $325.88…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

, IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

13:43
01/17/20
01/17
13:43
01/17/20
13:43
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

VB

Vanguard Small-Cap Index Fund

$169.72

-0.13 (-0.08%)

IVV

iShares Core S&P 500

$333.10

0.72 (0.22%)

TLT

iShares 20+ Year Treasury Bond Fund

$138.05

-1.15 (-0.83%)

ESGU

iShares ESG MSCI U.S.A. ETF

$73.74

0.27 (0.37%)

VCSH

Vanguard Short-Term Corporate Bond Index Fund

$81.21

0.025 (0.03%)

SPY

SPDR S&P 500 ETF Trust

$331.63

0.73 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$326.27

-5.73 (-1.73%)

13:42
01/17/20
01/17
13:42
01/17/20
13:42
Periodicals
ABC learns of another software issue with Boeing 737 Max »

ABC's David Kerley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

JNJ

Johnson & Johnson

$148.97

0.72 (0.49%)

13:39
01/17/20
01/17
13:39
01/17/20
13:39
Periodicals
Judge slashes J&J verdict down to $6.8M from $8B in Risperdal suit, Law.com says »

Philadelphia Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

JNJ

Johnson & Johnson

$149.03

0.78 (0.53%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Periodicals
Judge cuts J&J punishment in Risperdal case to $6.8M from $8B, Bloomberg reports »

On October 8, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Mar

  • 17

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/17/20
01/17
13:17
01/17/20
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/17/20
01/17
13:16
01/17/20
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$23.56

0.06 (0.26%)

13:04
01/17/20
01/17
13:04
01/17/20
13:04
Hot Stocks
Baker Hughes reports U.S. rig count up 15 to 796 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.